"Cell Cycle Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.
| Descriptor ID |
D018797
|
| MeSH Number(s) |
D12.776.167
|
| Concept/Terms |
Cell Cycle Proteins- Cell Cycle Proteins
- Cell Division Cycle Proteins
- Cell-Cycle Regulatory Proteins
- Cell Cycle Regulatory Proteins
- cdc Proteins
|
Below are MeSH descriptors whose meaning is more general than "Cell Cycle Proteins".
Below are MeSH descriptors whose meaning is more specific than "Cell Cycle Proteins".
This graph shows the total number of publications written about "Cell Cycle Proteins" by people in this website by year, and whether "Cell Cycle Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 1 | 2 |
| 2000 | 4 | 2 | 6 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 4 | 1 | 5 |
| 2004 | 2 | 2 | 4 |
| 2005 | 10 | 4 | 14 |
| 2006 | 3 | 0 | 3 |
| 2007 | 5 | 1 | 6 |
| 2008 | 2 | 4 | 6 |
| 2009 | 1 | 6 | 7 |
| 2010 | 5 | 2 | 7 |
| 2011 | 5 | 3 | 8 |
| 2012 | 5 | 3 | 8 |
| 2013 | 4 | 0 | 4 |
| 2014 | 4 | 3 | 7 |
| 2015 | 7 | 7 | 14 |
| 2016 | 1 | 3 | 4 |
| 2017 | 4 | 2 | 6 |
| 2018 | 4 | 1 | 5 |
| 2019 | 3 | 2 | 5 |
| 2020 | 3 | 2 | 5 |
| 2021 | 5 | 3 | 8 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.
-
Quantitative Top-down Proteomics Revealed Kinase Inhibitor-Induced Proteoform-Level Changes in Cancer Cells. J Proteome Res. 2025 Jan 03; 24(1):303-314.
-
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. Mol Cancer Ther. 2024 Jul 02; 23(7):911-923.
-
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801.
-
The cohesin modifier ESCO2 is stable during DNA replication. Chromosome Res. 2023 01 28; 31(1):6.
-
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. J Clin Oncol. 2023 03 20; 41(9):1725-1734.
-
A Novel Translational Activation of HIF1a Promotes Pancreatic Cancer Growth Through Glycolytic Reprogramming. Gastroenterology. 2022 04; 162(4):1040-1042.
-
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis. Mol Cancer. 2021 11 10; 20(1):145.
-
Ycs4 Subunit of Saccharomyces cerevisiae Condensin Binds DNA and Modulates the Enzyme Turnover. Biochemistry. 2021 11 16; 60(45):3385-3397.
-
The CRL4DTL E3 ligase induces degradation of the DNA replication initiation factor TICRR/TRESLIN specifically during S phase. Nucleic Acids Res. 2021 10 11; 49(18):10507-10523.
-
Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma. Drug Discov Ther. 2021 Sep 22; 15(4):204-209.